Gland Pharma appoints Satnam Singh Loomba as COO

Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.

Gland Pharma has appointed Satnam Singh Loomba as Chief Operating Officer (COO), effective May 01, 2024.

Loomba is a senior pharmaceutical and management professional with an extensive background in multi-cultural, global environments for pharmaceutical Operations & Business and proficient in several multifunctional departments. He has over 30 years of experience in API Operations & Development, Global Supply Planning & Operations in Manufacturing, Formulations, Global Material Sourcing, Corporate Strategic Business Planning, and Global Supply Chain for Global Markets.

He has experience in managing operations in Formulations in Pharmaceuticals, Narcotics, Cosmetics, Food an Alternate medicine like Sterile Injectables, Infusions, Aerosol based Inhalers, Sprays, Lyophilized products, Insulin, Lozenges, etc. He has been instrumental in attaining accreditations from USFDA, MHRA, EDQM Cofepris, TGA, MCC, Health Canada, ANVISA, PMDA, KFDA.

Before joining Gland, Satnam was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.

Loomba has done his Master of Business Administration from University Business School, Chandigarh. He is also a graduate in Chemical Engineering from Andhra University, Visakhapatnam.